Spotlight On: Myasthenia Gravis

Access to New Treatments

The landscape for treating MG is promising. In the past few years, several new and effective treatments have been approved for MG. These targeted therapies have fewer side effects and may lead to better daily function and quality of life.

The challenge that remains is the ability to access these treatments. These new treatments have high costs that may be an issue for many people, including people who are uninsured or marginalized, as well as people who have good access to care.

The hope is that as newer therapies are approved and options for care expand, resources for  assistance will expand and the market will adjust so it’s available to all eligible patients.